These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 11257110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA.
    Cancer; 1999 Dec 01; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [Abstract] [Full Text] [Related]

  • 3. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene.
    Hes F, Zewald R, Peeters T, Sijmons R, Links T, Verheij J, Matthijs G, Leguis E, Mortier G, van der Torren K, Rosman M, Lips C, Pearson P, van der Luijt R.
    Hum Genet; 2000 Apr 01; 106(4):425-31. PubMed ID: 10830910
    [Abstract] [Full Text] [Related]

  • 4. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul 01; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B.
    Cancer Surv; 1995 Jul 01; 25():219-32. PubMed ID: 8718521
    [Abstract] [Full Text] [Related]

  • 7. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
    Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H.
    JAMA; 1995 Oct 11; 274(14):1149-51. PubMed ID: 7563486
    [Abstract] [Full Text] [Related]

  • 8. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
    Prowse AH, Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA, Maher ER.
    Am J Hum Genet; 1997 Apr 11; 60(4):765-71. PubMed ID: 9106522
    [Abstract] [Full Text] [Related]

  • 9. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT.
    J Med Genet; 1996 Apr 11; 33(4):328-32. PubMed ID: 8730290
    [Abstract] [Full Text] [Related]

  • 10. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG.
    Hum Mol Genet; 2001 May 01; 10(10):1019-27. PubMed ID: 11331612
    [Abstract] [Full Text] [Related]

  • 11. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
    Iida K, Okimura Y, Takahashi K, Inomata S, Iguchi G, Kaji H, Chihara K.
    Int J Mol Med; 2004 Mar 01; 13(3):401-4. PubMed ID: 14767570
    [Abstract] [Full Text] [Related]

  • 14. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z.
    Am J Pathol; 1996 Dec 01; 149(6):2089-94. PubMed ID: 8952541
    [Abstract] [Full Text] [Related]

  • 15. Genotype-phenotype correlations in VHL exon deletions.
    McNeill A, Rattenberry E, Barber R, Killick P, MacDonald F, Maher ER.
    Am J Med Genet A; 2009 Oct 01; 149A(10):2147-51. PubMed ID: 19764026
    [Abstract] [Full Text] [Related]

  • 16. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
    Gallou C, Chauveau D, Richard S, Joly D, Giraud S, Olschwang S, Martin N, Saquet C, Chrétien Y, Méjean A, Correas JM, Benoît G, Colombeau P, Grünfeld JP, Junien C, Béroud C.
    Hum Mutat; 2004 Sep 01; 24(3):215-24. PubMed ID: 15300849
    [Abstract] [Full Text] [Related]

  • 17. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.
    Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson-Smith MA, Brauch H, Glavac D, Neumann HP, Tisherman S, Mulvihill JJ, Gross DJ, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips CH, Lerman M.
    Hum Mutat; 1996 Sep 01; 8(4):348-57. PubMed ID: 8956040
    [Abstract] [Full Text] [Related]

  • 18. Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations.
    Ruiz-Llorente S, Bravo J, Cebrián A, Cascón A, Pollan M, Tellería D, Letón R, Urioste M, Rodríguez-López R, de Campos JM, Muñoz MJ, Lacambra C, Benítez J, Robledo M.
    Hum Mutat; 2004 Feb 01; 23(2):160-169. PubMed ID: 14722919
    [Abstract] [Full Text] [Related]

  • 19. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M, Jamil M, Aslam M, Abalkhail H, Al-Dayel F, Basit S, Nawaz Z, Zaidi SHE.
    Cancer Genet; 2020 May 01; 243():1-6. PubMed ID: 32179488
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.